This slide presentation presents the practice parameters developed from the guideline, Practice Parameter: Immunotherapy for Guillain-Barré Syndrome. The objective of the guideline is to provide an evidence-based statement to guide physicians in the management of Guillain-Barré syndrome (GBS).
This presentation addresses the following clinical questions:
Also included are suggestions for future research as well as a summary of the American Academy of Neurology recommendations for immunotherapy for GBS.
American Academy of Neurology
Last updated: July 28, 2009.
AHRQ Home |
Contact AHRQ |
Site Map |
Freedom of Information Act |
Plain Writing Act
U.S. Department of Health & Human Services |
The White House |
USA.gov: The U.S. Government's Official Web Portal
Agency for Healthcare Research and Quality 540 Gaither Road Rockville, MD 20850 Telephone: (301) 427-1364